FDA approves first gene therapy for Sanfilippo syndrome type A
FDA approves first gene therapy for Sanfilippo syndrome type A Pharmaceutical Technology
Finance, IT & News
FDA approves first gene therapy for Sanfilippo syndrome type A Pharmaceutical Technology
FDA approves imlunestrant plus abemaciclib for ESR1-mutated breast cancer The Clinical Trial Vanguard
Luxury London punk fashion boutique wins approval for Miami Beach flagship store Miami Herald
FDA Approves Imlunestrant Combo in ESR1-Mutated Breast Cancer CancerNetwork
FDA Approves Levacetylleucine for Ataxia-Telangiectasia NeurologyLive